News
-
-
-
COMMUNIQUÉ DE PRESSE
Lobe Sciences Reports Third Quarter 2026 Financial Results
Lobe Sciences Ltd. announces unaudited financial results for Q3 2026, showing progress in R&D and capital allocation. Equity position increased. Private placements closed and announced. Subsidiaries focusing on drugs for neurological and psychiatric disorders -
-
-
-
-
-
-